instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Appendicitis'? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | Recovered | ReactionOutcome | CC BY | 33288862 | 18,658,791 | 2021-05 |
What was the outcome of reaction 'Nausea'? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | Recovered | ReactionOutcome | CC BY | 33288862 | 18,658,791 | 2021-05 |
What was the outcome of reaction 'Vomiting'? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | Recovered | ReactionOutcome | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema.
Only a few earlier clinical radiologic reports exist describing post-COVID-19 pulmonary fibrosis. We report a case of 74-year-old woman referred with dizziness and hypoxemic respiratory failure with chest high resolution computer tomogra... | AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC-ND | 33288987 | 19,138,872 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema.
Only a few earlier clinical radiologic reports exist describing post-COVID-19 pulmonary fibrosis. We report a case of 74-year-old woman referred with dizziness and hypoxemic respiratory failure with chest high resolution computer tomogra... | AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY-NC-ND | 33288987 | 19,138,872 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastatic renal cell carcinoma'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | CABOZANTINIB, CINACALCET HYDROCHLORIDE, DENOSUMAB, FUROSEMIDE, METHYLPREDNISOLONE, NIVOLUMAB, PAZOPANIB, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the administration route of drug 'CINACALCET HYDROCHLORIDE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the administration route of drug 'DENOSUMAB'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the administration route of drug 'FUROSEMIDE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the dosage of drug 'DENOSUMAB'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | 120 MILLIGRAM, Q4WK | DrugDosageText | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the dosage of drug 'FUROSEMIDE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | 40 MILLIGRAM | DrugDosageText | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | 40 MILLIGRAM, ONE TIME DOSE | DrugDosageText | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | 1 LITER | DrugDosageText | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the outcome of reaction 'Hypercalcaemia'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Recovered | ReactionOutcome | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
What was the outcome of reaction 'Metastatic renal cell carcinoma'? | Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process.... | Fatal | ReactionOutcome | CC BY-NC-ND | 33289687 | 19,258,843 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Coombs-negative haemolytic anaemia in pregnancy: A case report.
We present a rare case of Coombs-negative autoimmune haemolytic anaemia in a multiparous woman in secondary care. There were no known underlying medical or obstetric risk factors for haemolytic anaemia. Following extensive investigation and a therapeutic t... | ASPIRIN, FOLIC ACID, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33294391 | 18,792,533 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Coombs-negative haemolytic anaemia in pregnancy: A case report.
We present a rare case of Coombs-negative autoimmune haemolytic anaemia in a multiparous woman in secondary care. There were no known underlying medical or obstetric risk factors for haemolytic anaemia. Following extensive investigation and a therapeutic t... | ASPIRIN, DEXTROSE, FERRIC CARBOXYMALTOSE, FOLIC ACID, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33294391 | 18,802,221 | 2021-01 |
What was the administration route of drug 'FERRIC CARBOXYMALTOSE'? | Coombs-negative haemolytic anaemia in pregnancy: A case report.
We present a rare case of Coombs-negative autoimmune haemolytic anaemia in a multiparous woman in secondary care. There were no known underlying medical or obstetric risk factors for haemolytic anaemia. Following extensive investigation and a therapeutic t... | Other | DrugAdministrationRoute | CC BY-NC-ND | 33294391 | 18,802,221 | 2021-01 |
What was the administration route of drug 'PREDNISOLONE'? | Coombs-negative haemolytic anaemia in pregnancy: A case report.
We present a rare case of Coombs-negative autoimmune haemolytic anaemia in a multiparous woman in secondary care. There were no known underlying medical or obstetric risk factors for haemolytic anaemia. Following extensive investigation and a therapeutic t... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33294391 | 18,802,221 | 2021-01 |
What was the outcome of reaction 'Gestational diabetes'? | Coombs-negative haemolytic anaemia in pregnancy: A case report.
We present a rare case of Coombs-negative autoimmune haemolytic anaemia in a multiparous woman in secondary care. There were no known underlying medical or obstetric risk factors for haemolytic anaemia. Following extensive investigation and a therapeutic t... | Recovering | ReactionOutcome | CC BY-NC-ND | 33294391 | 18,802,221 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood testosterone decreased'. | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33294761 | 18,656,149 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | ABIRATERONE ACETATE, BICALUTAMIDE, DEGARELIX, LEUPROLIDE ACETATE, PREDNISONE | DrugsGivenReaction | CC BY | 33294761 | 18,916,525 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostate cancer'. | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | ABIRATERONE ACETATE, BICALUTAMIDE, DEGARELIX, LEUPROLIDE ACETATE, PREDNISONE | DrugsGivenReaction | CC BY | 33294761 | 18,916,525 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatic specific antigen abnormal'. | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 33294761 | 18,656,149 | 2021-01-01 |
What was the outcome of reaction 'Adrenogenital syndrome'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Recovered | ReactionOutcome | CC BY | 33294761 | 18,916,528 | 2021-01-01 |
What was the outcome of reaction 'Blood testosterone decreased'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Recovering | ReactionOutcome | CC BY | 33294761 | 18,656,149 | 2021-01-01 |
What was the outcome of reaction 'Blood testosterone increased'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Recovered | ReactionOutcome | CC BY | 33294761 | 18,916,528 | 2021-01-01 |
What was the outcome of reaction 'Prostate cancer'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Not recovered | ReactionOutcome | CC BY | 33294761 | 18,916,525 | 2021-01-01 |
What was the outcome of reaction 'Prostatic specific antigen abnormal'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Recovering | ReactionOutcome | CC BY | 33294761 | 18,656,149 | 2021-01-01 |
What was the outcome of reaction 'Prostatic specific antigen increased'? | Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple pot... | Recovered | ReactionOutcome | CC BY | 33294761 | 18,916,528 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, ... | CAPECITABINE, PASIREOTIDE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33294765 | 20,443,328 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, ... | CAPECITABINE, PASIREOTIDE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33294765 | 20,443,328 | 2021-01-01 |
What was the administration route of drug 'PASIREOTIDE'? | Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, ... | Intramuscular | DrugAdministrationRoute | CC BY-NC-ND | 33294765 | 20,443,328 | 2021-01-01 |
What was the outcome of reaction 'Hyperglycaemia'? | Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33294765 | 20,443,328 | 2021-01-01 |
What was the outcome of reaction 'Product use in unapproved indication'? | Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia.
Tumor-induced hypoglycemia is a serious disorder most commonly caused by insulinoma or non-islet cell tumor hypoglycemia (NICTH). The hypoglycemia can be severe and refractory to conventional therapy, ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33294765 | 20,443,328 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
BACKGROUND
Advanced therapy-refractory parotid gland carcinomas have a poor prognosis with limited therapy options. We used molecular profiling to offer molecular guided therapies to patients with advanced metastatic parotid gland malignancie... | DOCETAXEL, SUNITINIB | DrugsGivenReaction | CC BY | 33296026 | 19,253,223 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
BACKGROUND
Advanced therapy-refractory parotid gland carcinomas have a poor prognosis with limited therapy options. We used molecular profiling to offer molecular guided therapies to patients with advanced metastatic parotid gland malignancie... | DOCETAXEL, SUNITINIB | DrugsGivenReaction | CC BY | 33296026 | 19,253,223 | 2021-01 |
What was the administration route of drug 'SUNITINIB'? | Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
BACKGROUND
Advanced therapy-refractory parotid gland carcinomas have a poor prognosis with limited therapy options. We used molecular profiling to offer molecular guided therapies to patients with advanced metastatic parotid gland malignancie... | Oral | DrugAdministrationRoute | CC BY | 33296026 | 19,253,223 | 2021-01 |
What was the dosage of drug 'SUNITINIB'? | Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
BACKGROUND
Advanced therapy-refractory parotid gland carcinomas have a poor prognosis with limited therapy options. We used molecular profiling to offer molecular guided therapies to patients with advanced metastatic parotid gland malignancie... | 50 mg (milligrams). | DrugDosage | CC BY | 33296026 | 19,253,223 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate that targets aminopeptidases and rapidly and selectively releases alkylating agents into tumor cells. The phase II HORIZON trial evaluated the efficacy... | AZACITIDINE | DrugsGivenReaction | CC BY-NC-ND | 33296242 | 19,180,518 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate that targets aminopeptidases and rapidly and selectively releases alkylating agents into tumor cells. The phase II HORIZON trial evaluated the efficacy... | AZACITIDINE | DrugsGivenReaction | CC BY-NC-ND | 33296242 | 19,180,518 | 2021-03-01 |
What was the outcome of reaction 'Fungal infection'? | Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate that targets aminopeptidases and rapidly and selectively releases alkylating agents into tumor cells. The phase II HORIZON trial evaluated the efficacy... | Fatal | ReactionOutcome | CC BY-NC-ND | 33296242 | 19,180,518 | 2021-03-01 |
What was the outcome of reaction 'Neutropenia'? | Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate that targets aminopeptidases and rapidly and selectively releases alkylating agents into tumor cells. The phase II HORIZON trial evaluated the efficacy... | Fatal | ReactionOutcome | CC BY-NC-ND | 33296242 | 19,180,518 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial sepsis'. | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | NYSTATIN, TERBINAFINE | DrugsGivenReaction | CC BY | 33299794 | 18,688,888 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia aspiration'. | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | NYSTATIN, TERBINAFINE | DrugsGivenReaction | CC BY | 33299794 | 18,688,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | NYSTATIN, TERBINAFINE | DrugsGivenReaction | CC BY | 33299794 | 18,688,885 | 2021 |
What was the outcome of reaction 'Bacterial sepsis'? | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | Fatal | ReactionOutcome | CC BY | 33299794 | 18,688,888 | 2021 |
What was the outcome of reaction 'Pneumonia aspiration'? | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | Fatal | ReactionOutcome | CC BY | 33299794 | 18,688,885 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Experience of treating Candida auris cases at a general hospital in the state of Qatar.
So far there have been no studies on Candida auris in Qatar. This study aimed to describe the clinical spectrum and outcome of C. auris infection in patients admitted to a general hospital in Qatar.
We conducted this descriptive obs... | Fatal | ReactionOutcome | CC BY | 33299794 | 18,688,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autoimmune hepatitis'. | Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma.
Azoospermia is classified as the complete absence of sperm in ejaculate and accounts for 10-15% of male infertility. Many anticancer drugs are known to cause defects in spermatogenesis, but the effects of immune checkpo... | IPILIMUMAB, MYCOPHENOLIC ACID, NIVOLUMAB, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33299797 | 18,683,511 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Azoospermia'. | Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma.
Azoospermia is classified as the complete absence of sperm in ejaculate and accounts for 10-15% of male infertility. Many anticancer drugs are known to cause defects in spermatogenesis, but the effects of immune checkpo... | IPILIMUMAB, MYCOPHENOLIC ACID, NIVOLUMAB, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33299797 | 18,683,511 | 2021-01 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma.
Azoospermia is classified as the complete absence of sperm in ejaculate and accounts for 10-15% of male infertility. Many anticancer drugs are known to cause defects in spermatogenesis, but the effects of immune checkpo... | 2MG EVERYDAY | DrugDosageText | CC BY-NC-ND | 33299797 | 18,683,511 | 2021-01 |
What was the outcome of reaction 'Libido decreased'? | Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma.
Azoospermia is classified as the complete absence of sperm in ejaculate and accounts for 10-15% of male infertility. Many anticancer drugs are known to cause defects in spermatogenesis, but the effects of immune checkpo... | Recovered | ReactionOutcome | CC BY-NC-ND | 33299797 | 20,229,188 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Heterogeneous tumor-immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti-PD-L1 antibody therapy.
A pulmonary carcinoid tumor is a rare tumor that lacks a validated therapeutic approach for unresectable disease. Understanding the intersite tumor-immune heterogeneity is ... | ATEZOLIZUMAB, CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 33300302 | 19,744,836 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Intranasal lidocaine atomization as novel and noninvasive treatment option for postdural puncture headache : Two case reports from obstetric anesthesiology.
Postdural puncture headache (PDPH) occurs in up to 11% of patients after spinal anesthesia and in more than 80% after dural perforation upon epidural anesthesia. I... | ACETAMINOPHEN, CAFFEINE, DIMENHYDRINATE, IBUPROFEN | DrugsGivenReaction | CC BY | 33301057 | 20,099,098 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Metastatic renal cell carcinoma to the prostate and seminal vesicle.
Renal cell carcinoma (RCC) a common malignancy with potential to metastasize to visceral organs. However, it uncommonly spreads to the lower genitourinary tract. We present a man with a history of RCC status post radical nephrectomy in April 2012. He ... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 33304825 | 18,650,969 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetic ketoacidosis'. | Metastatic renal cell carcinoma to the prostate and seminal vesicle.
Renal cell carcinoma (RCC) a common malignancy with potential to metastasize to visceral organs. However, it uncommonly spreads to the lower genitourinary tract. We present a man with a history of RCC status post radical nephrectomy in April 2012. He ... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 33304825 | 18,650,969 | 2021-01 |
What was the outcome of reaction 'Diabetes mellitus'? | Metastatic renal cell carcinoma to the prostate and seminal vesicle.
Renal cell carcinoma (RCC) a common malignancy with potential to metastasize to visceral organs. However, it uncommonly spreads to the lower genitourinary tract. We present a man with a history of RCC status post radical nephrectomy in April 2012. He ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33304825 | 18,650,969 | 2021-01 |
What was the outcome of reaction 'Diabetic ketoacidosis'? | Metastatic renal cell carcinoma to the prostate and seminal vesicle.
Renal cell carcinoma (RCC) a common malignancy with potential to metastasize to visceral organs. However, it uncommonly spreads to the lower genitourinary tract. We present a man with a history of RCC status post radical nephrectomy in April 2012. He ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33304825 | 18,650,969 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glucocorticoid deficiency'. | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | ASPIRIN, METYRAPONE, NIFEDIPINE | DrugsGivenReaction | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | ASPIRIN, METYRAPONE, NIFEDIPINE | DrugsGivenReaction | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the administration route of drug 'ASPIRIN'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the administration route of drug 'METYRAPONE'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the administration route of drug 'NIFEDIPINE'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the dosage of drug 'NIFEDIPINE'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | 60 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the outcome of reaction 'Glucocorticoid deficiency'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | Recovered | ReactionOutcome | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone.
Adrenal Cushing syndrome during pregnancy is rare, and there is limited information on the effect and safety of metyrapone treatment both for mother and fetus. We present a 24-year-old woman diagnosed with adrenal Cushin... | Recovered | ReactionOutcome | CC BY-NC-ND | 33305159 | 18,699,300 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Undifferentiated carcinoma of the liver in a 3-year-old girl treated by neoadjuvant chemotherapy and complete resection.
BACKGROUND
Undifferentiated carcinoma (UC) of the liver has only been reported in three adults in the English language literature and is so rare it has never been reported in a child. Our management ... | CISPLATIN, DOXORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33310474 | 19,165,864 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | Undifferentiated carcinoma of the liver in a 3-year-old girl treated by neoadjuvant chemotherapy and complete resection.
BACKGROUND
Undifferentiated carcinoma (UC) of the liver has only been reported in three adults in the English language literature and is so rare it has never been reported in a child. Our management ... | CISPLATIN, DOXORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33310474 | 19,165,864 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Undifferentiated carcinoma of the liver in a 3-year-old girl treated by neoadjuvant chemotherapy and complete resection.
BACKGROUND
Undifferentiated carcinoma (UC) of the liver has only been reported in three adults in the English language literature and is so rare it has never been reported in a child. Our management ... | CISPLATIN, DOXORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33310474 | 19,165,864 | 2021-01 |
What was the outcome of reaction 'Neoplasm progression'? | Undifferentiated carcinoma of the liver in a 3-year-old girl treated by neoadjuvant chemotherapy and complete resection.
BACKGROUND
Undifferentiated carcinoma (UC) of the liver has only been reported in three adults in the English language literature and is so rare it has never been reported in a child. Our management ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33310474 | 19,165,864 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | ASPIRIN | DrugsGivenReaction | CC BY | 33313931 | 20,187,437 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small for dates baby'. | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | ASPIRIN | DrugsGivenReaction | CC BY | 33313931 | 20,187,437 | 2021-07-01 |
What is the weight of the patient? | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | .511 kg. | Weight | CC BY | 33313931 | 20,187,437 | 2021-07-01 |
What was the administration route of drug 'ASPIRIN'? | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | Transplacental | DrugAdministrationRoute | CC BY | 33313931 | 20,187,437 | 2021-07-01 |
What was the administration route of drug 'HYDROXYCHLOROQUINE SULFATE'? | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | Transplacental | DrugAdministrationRoute | CC BY | 33313931 | 20,186,598 | 2021-07-01 |
What was the dosage of drug 'HYDROXYCHLOROQUINE SULFATE'? | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | (MATERNAL DOSE: 200 MG QD) | DrugDosageText | CC BY | 33313931 | 20,186,598 | 2021-07-01 |
What was the dosage of drug 'METHYLDOPA'? | Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
Pregnancy in SSc is burdened with an increased risk of obstetric complications. Little is known about the underlying placental alterations. This study aimed to better understand pathologic... | (MATERNAL DOSE: UNKNOWN) | DrugDosageText | CC BY | 33313931 | 20,186,598 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactate dehydrogenase increased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gamma-glutamyltransferase increased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glioblastoma multiforme'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Monocyte count decreased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count decreased'. | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | ARTESUNATE, CLOBAZAM, DIVALPROEX SODIUM, LEVETIRACETAM, LORAZEPAM, ONDANSETRON, TEMOZOLOMIDE, VALPROIC ACID | DrugsGivenReaction | CC BY | 33313992 | 15,046,217 | 2021-06 |
What was the administration route of drug 'ARTESUNATE'? | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | Oral | DrugAdministrationRoute | CC BY | 33313992 | 15,046,217 | 2021-06 |
What was the administration route of drug 'CLOBAZAM'? | Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Background Precision medicine and drug repurposing are attractive strategies, especially for tumors with worse prognosis. Glioblastoma is a highly malignant brain tumor with limited treatment options and short sur... | Oral | DrugAdministrationRoute | CC BY | 33313992 | 15,046,217 | 2021-06 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.